4D Molecular Therapeutics, Inc. (FDMT)
Biological Products, (No Diagnostic Substances)
Latest Price
$10.18
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
6.64
P/B Ratio
1.53
Institutional Ownership
89.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.25M | $48.0M | 10.04% | +611.3K | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 5.05M | $47.0M | 9.66% | -603.4K | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 4.21M | $39.0M | 8.05% | -97.5K | 2026-03-31 |
| BlackRock, Inc. | 4.15M | $38.0M | 7.93% | +80.4K | 2026-03-31 |
| NOVO HOLDINGS A/S | 3.65M | $33.0M | 6.98% | -- | 2026-03-31 |
| BVF INC/IL | 2.88M | $26.0M | 5.51% | -1.75M | 2026-03-31 |
| STATE STREET CORP | 2.71M | $25.0M | 5.18% | +19.0K | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 2.00M | $18.0M | 3.83% | +64.0K | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.61M | $14.0M | 3.07% | +370.0K | 2026-03-31 |
| FEDERATED HERMES, INC. | 1.43M | $13.0M | 2.74% | -177.2K | 2026-03-31 |